Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

Global medical device company Medtronic announced Wednesday that it intends to separate its diabetes business into a ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

Medtronic expects Trump administration tariffs and reciprocal tariffs from other countries to cost it $200–350 million over ...

Finally, Medtronic remains an excellent dividend stock, and it recently announced yet another payout hike. The medical device ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medtronic upgraded to 'Strong Buy' with $104 fair value. Diabetes spin-off boosts focus on core markets, driving growth, ...

Under Medtronic’s plan, the new unnamed company will also be publicly traded, Medtronic said. The diabetes business generated nearly $2.8 billion in sales in its most recent fiscal year ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...